Xiaoling Cheng

22PUBLICATIONS
31CO-AUTHORS
Haematological tumoursInfant and child healthEpidemiological methodsEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 17, 2026
Safety of sirolimus in pediatric vascular anomalies: a BKMR-PopPK exposure-response framework for individualized risk and dosing.

|Jul 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical care.

Jingyao Ma, Chang Cui, Juntao Ouyang

|Jan 05, 2025
Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational study.

Nan Wang, Zhifa Wang, Jingjing Liu

|Dec 25, 2024
Real-world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center.

Qianqian Mao, Zhenping Chen, Guoqing Liu

|Sep 03, 2024
Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopenia guided by therapeutic drug monitoring.

Shuyue Dong, Zhifa Wang, Nan Wang

|Jun 24, 2024
Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL.

Zhengping Li, Jie Sun, Zekun Li

Pageof 4

Frequent Collaborators

15 joint publications

Runhui Wu

9 joint publications

Zhifa Wang

8 joint publications

Zhenping Chen

5 joint publications

Man-Chiu Poon